Drug profile · INN
butoconazole nitrate
FEMSTAT
butoconazole nitrate (FEMSTAT) is a cytochrome p450 51 inhibitor. Route of administration: vaginal. Current US regulatory status: approved.
Drug details — butoconazole nitrate
- US status
- approved
- Class
- —
- Route
- VAGINAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
butoconazole nitrate (FEMSTAT) is a cytochrome p450 51 inhibitor. Route of administration: vaginal. Current US regulatory status: approved.
Key facts
Mechanism of action
Cytochrome P450 51 inhibitor
Primary target: Lanosterol 14-alpha demethylase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is butoconazole nitrate?
butoconazole nitrate (FEMSTAT) is a cytochrome p450 51 inhibitor. Route of administration: vaginal. Current US regulatory status: approved.
What is the brand name for butoconazole nitrate?
FEMSTAT is a marketed brand name for butoconazole nitrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of butoconazole nitrate?
butoconazole nitrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.